Participez aux événements d'Alsace BioValley !

Retour aux événements
09 Juin
du 09 juin 2015 au 12 juin 2015 Journée complète payant
Palais Universitaire - 9, Place de l'Université 67000 Strasbourg - Plan d'accès

2nd NovAliX Conference : Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

Je m'inscris / I want to register

Conférence BIOPHYSICS IN DRUG DISCOVERY 2015 NovAlix NovAliX organise pour la 2ème année la Conférence Biophysics in Drug Discovery sur le thème « Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs« .

Programme

The programme will cover the following topics:

  • Method Development & Emerging Technologies
  • Biophysics for Integral Membrane Proteins
  • Impact of Biophysics on Drug Discovery Projects
  • Use of Kinetics in Drug Discovery
  • Epigenetics (Special Focus of the conference)

Discover the program

To submit abstracts for posters

Abstract submission for oral communications is now closed, but it is still possible to submit abstracts for poster presentations, with the prior payment of 50,00€ handling fees.
Thank you to register before you complete the online form below

Submit your abstract(s) now

Poster submission is final as of May 8, 2015.

Register now!

20150609-12_Conference NovAliX

Accomodation in Strasbourg

We would like to draw your attention on the fact that during the same week of June a session of the European Parliament will take place in Strasbourg. We therefore strongly recommend to book your accommodation well in advance as rooms at reasonable rates might be difficult to find! A selection of hotels is now available for booking via the symposium website.
Book your hotel now!

About the first edition

After the success of the first NovAlix Conference focusing on ‘Biophysics in Drug Discovery’, held in October 2013 in Strasbourg with more than 160 people from 20 countries, the second edition of the conference intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline.